Professional Summary
Professional Overview
James Hackworth is a seasoned healthcare executive with extensive experience in business development, corporate strategy, and commercialization. As the Chief Business Officer at Tris Pharma, he is responsible for driving the company's strategic initiatives, managing partnerships, and overseeing the overall business operations. Hackworth's deep industry expertise and proven track record of success make him a valuable asset in the pharmaceutical and biotechnology sectors.
Experience Summary
Current Role
As the Chief Business Officer at Tris Pharma, Hackworth is responsible for leading the company's business development activities, forging strategic partnerships, and overseeing the commercialization of Tris Pharma's product portfolio. He has been instrumental in expanding the company's reach and securing lucrative collaborations with industry leaders. Under his guidance, Tris Pharma has achieved significant milestones, positioning the company for continued growth and success.
Career Progression
Prior to his current role, Hackworth served as the President of the Brand Division at Tris Pharma, where he was instrumental in driving the company's commercial strategy and brand development initiatives. He has also held various leadership positions at DeepBiome Therapeutics, Inc. and Shionogi Inc., where he was responsible for corporate development, commercialization strategy, and business development. Hackworth's diverse background and extensive experience in the pharmaceutical and biotechnology industries have allowed him to make significant contributions to the field.
Academic Background
Hackworth holds a Bachelor's degree in Biomedical Engineering from the University of Michigan and a Master's degree in Business Administration from the Wharton School of the University of Pennsylvania. His academic achievements, combined with his practical industry experience, have equipped him with a unique blend of technical expertise and strategic business acumen.
Areas of Expertise
- Business development and strategic partnerships
- Corporate strategy and portfolio optimization
- Commercialization and product launch planning
- Mergers, acquisitions, and integration
- Leadership and team management
Professional Impact
Throughout his career, Hackworth has played a pivotal role in driving the growth and success of the companies he has been associated with. His contributions have been recognized through his involvement as an investor and steering committee member at Mid Atlantic Bio Angels, as well as his board memberships at Raya Therapeutics, Inc. and Elysium Therapeutics, Inc. Hackworth's deep industry knowledge, strategic vision, and collaborative approach have consistently made him a valuable asset to the organizations he has served.
Conclusion
James Hackworth is a seasoned healthcare executive with a proven track record of driving business success and industry impact. As the Chief Business Officer at Tris Pharma, he continues to leverage his extensive expertise and strategic acumen to steer the company's growth and solidify its position as a leading player in the pharmaceutical and biotechnology sectors.
